Pharyngitis:治療薬市場動向2014(市場規模、グローバルAPIメーカー、第Ⅲ相試験)

調査会社DelveInsight社が発行したリサーチレポート(データ管理コード:DIIR2014142)
◆英語タイトル: Pharyngitis- Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014
◆発行会社/調査会社:DelveInsight
◆商品コード:DIIR2014142
◆発行日:2014年版(※最新版はお問い合わせください)
◆調査対象地域:グローバル
◆産業分野:製薬
◆ページ数:75以上
◆レポート言語:英語
◆レポート形式:PDF
◆納品方式:Eメール
◆販売価格オプション(消費税別)
Single UserUSD2,000 ⇒換算¥226,000見積依頼/購入/質問フォーム
Site Price(同一国内共有可)USD4,000 ⇒換算¥452,000見積依頼/購入/質問フォーム
Enterprise Price(複数国内共有可)USD6,000 ⇒換算¥678,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(振込先:三菱UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
DelveInsight社の概要及び新刊レポートはこちらでご確認いただけます。

★グローバルリサーチ資料[Pharyngitis:治療薬市場動向2014(市場規模、グローバルAPIメーカー、第Ⅲ相試験)]についてメールでお問い合わせはこちら
*** レポート概要(サマリー)***

DelveInsight’s, “ Pharyngitis- Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014”, report provides comprehensive insights about phase III pipeline drugs and marketed drugs across the indication. A key objective of the report is to establish the understanding for API Manufacturers for marketed and Phase III pipeline drugs across the different countries and regions. While the leading brands, companies and chemicals are considered thoroughly, the report also provides details on the drug master filings across the US, Europe and Asia specifically China and India. The research, analysis also presents the global sales forecasts data till 2015. The report is also giving insight about the patent and exclusivity details of all the drugs across the indication.

Data Sources

The report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by DelveInsight team of industry experts.

Secondary sources information and data has been collected from various printable and non-printable sources like search engines, News websites, Government Websites, Trade Journals, White papers, Magazines, Trade associations, Books, Industry Portals, Industry Associations and access to available databases.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.


• A snapshot of the global Market therapeutics scenario for Pharyngitis.
• A review of the marketed products under prescription for Pharyngitis, regulatory information and marketing status.
• Coverage of global patent coverage and detailed commentaries on the US patent challenges.
• Graphical representation of investigational products for patent expiry and market exclusivities across the globe.
• Product profiles for marketed products for Pharyngitis with complete description of mechanism of action, therapeutic class, target, route(s) of administration and chemical details.
• Coverage of API Manufacturers for Pharyngitis drugs in the United States, Europe and Asian Regions with location details.
• Coverage of Regulatory filings in theUS, Europe, and Asia specifically India and China for Pharyngitis drugs.
• Coverage of Route of Synthesis of Active Pharmaceutical Ingredient associated with Pharyngitis drugs.
• Coverage of Pharyngitis Phase III pipeline products featuring sections on product description, mechanism of action, Chemical details and research & development progress.
• Coverage of the United States Drug Master File (US DMF) available for Phase III Pipeline Drugs.
• Key discontinued Marketed products.
• Global Sales Figure from 2011-2015.

• Evaluate the marketing status and exclusivity details of Pharyngitis key products to exploit opportunities for generic drug development opportunities.
• Identify and understand important and diverse types of therapeutics under Phase III development for Pharyngitis.
• Design effective counter-strategies to gain competitive advantage by identifying the key patent expiry details and exclusivity with respect to ‘Disease’.
• API intelligence over marketed drugs for Pharyngitis and gaining primary intelligence over active ingredients manufacturers across the globe.
• API intelligence over leading Phase III pipeline drugs.
• Develop and designstrategies by identifying the API manufacturers for Phase III pipeline products to enhance and expand business potential and scope.
• Understanding the scope of the Phase III Drugs with nil regulatory filings.
• Understanding the chemical route of synthesis of approved drugs for Pharyngitis.
• Uncovering opportunities in the rapidly growing the US markets.

*** レポート目次(コンテンツ)***

• Indication Overview
• Marketed Drugs Assessment
• Marketed Details of Drugs by Application Type
• Marketed Details of Drugs (NDA) by Marketing Status
• Marketed Details of Drugs by Patent Expiration Timeline
• The Active Pharmaceutical Ingredient (API) Manufacturers Assessment
• The API Manufacturers by the United States Drug Master File (US DMF) Status
• The API Manufacturers by the US DMF Status (Drug Specific)
• The Active Pharmaceutical Ingredient (API) Manufacturers Assessment for Phase III Pipeline Drugs
• The API Manufacturers by the US DMF Status (Drug Specific)
• Drugs Market Data and Forecasted Sales Figures (2011-2015)
• Marketed Drugs Information
• Drugs Description
• Route of Synthesis
• Global Active Pharmaceutical Manufacturers
• Approval Status
• Patent and Exclusivity Details
• Company Overview
• Phase III Drugs Information
• Phase III Drugs Description
• The United States Drug Master Filings (US DMF)
• Discontinued Drugs Information

Pharyngitis Therapeutic Market, US, Marketed Drugs by Application Type, 2014
Pharyngitis Therapeutic Market, US, Marketed Drugs by Marketing Status, 2014
Pharyngitis Therapeutic Market, US, (Year), 2014
Pharyngitis Marketed Drugs, API Manufacturers by US DMF Status, 2014
Pharyngitis Marketed Drugs, US DMF Status Drug Specific (Number), 2014
Pharyngitis Phase III Pipeline Drugs, US DMF Status Drug Specific (Number), 2014
Pharyngitis Therapeutic Market, Global Sales (in million USD), 2014
Pharyngitis Marketed Drugs, API Manufacturers, Global, 2014
Pharyngitis Phase III Pipeline Drugs, United States Drug Master File (DMF), 2014
Discontinued Drugs for Pharyngitis, 2014

Pharyngitis Therapeutic Market, US, Marketed Drugs by Application Type (%), 2014
Pharyngitis Therapeutic Market, US, Marketed Drugs by Marketing Status (%), 2014
Pharyngitis Therapeutic Market, US, (Year), 2014
Pharyngitis Marketed Drugs, API Manufacturers by US DMF Status (%), 2014
Pharyngitis Marketed Drugs, US DMF Status Drug Specific (Number), 2014
Pharyngitis Phase III Pipeline Drugs, US DMF Status Drug Specific (Number), 2014
Pharyngitis Therapeutic Market, Global Sales (in million USD), 2014
Pharyngitis Marketed Drugs, Patent/Exclusivity Expiry (Year), 2014

*** 掲載企業 ***

Corden Pharma International GmbH
Eli Lilly and Company
AbbVie Inc.
Pfizer Inc.
UCB S.A.
Vansen Pharma
Shionogi Inc.
Lupin Pharmaceuticals, Inc.
Lilly USA, LLC
Pernix Therapeutics Holdings, Inc.
Bristol-Myers Squibb Company
Mayne Pharma Limited
Hospira, Inc.
Endo Pharmaceuticals Inc.
UCB, Inc.
Fisons Limited
Johnson & Johnson
GlaxoSmithKline Inc.
ANI Pharmaceuticals, Inc.
King Pharmaceuticals Ltd
Merck & Co., Inc.
Novartis Pharmaceuticals Corporation
Wyeth (Inactive)
Mallinckrodt plc
Novartis AG
Schwarz Pharma AG
Alza Corporation
sanofi-aventis U.S. LLC.
Forest Laboratories, Inc.
Bayer HealthCare Pharmaceuticals Inc.
Warner Chilcott Plc
Banner Pharmacaps, Inc.
Teva Pharmaceuticals USA, Inc.
McNeil Consumer Healthcare
Hawthorn Pharmaceuticals, Inc.

*** レポートのキーワード ***

Pharyngitis、医薬品、治療薬、規模、販売量、医薬品有効成分(API)メーカー、第Ⅲ相試験、製薬

*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/


※おすすめ調査資料
  • ウクライナのホルムアルデヒド市場2015-2019
    About The report brings together facts and figures about formaldehyde market in Ukraine covering period of 2009-2019. Statistics, experts’ opinions and estimations are given. The report about formaldehyde market in Ukraine covers: - manufacturers capacity, production volumes - company profiles - con …
  • 船舶用プロペラの世界市場:可変ピッチ式、固定ピッチ式、ダクトプロペラ
    The marine propeller market is estimated to be USD 4.61 Billion in 2015 and is projected to reach USD 5.06 Billion by 2020 at a CAGR of 1.88%. The market is driven by the growth in global trade and shipbuilding industry in countries such as China, Japan and South Korea. There is also an increase in …
  • ヨーロッパの製油業動向:生産能力、投資予測
    Refining Industry Outlook in Europe to 2019 - Capacity and Capital Expenditure Forecasts with Details of All Operating and Planned Refineries Summary "Refining Industry Outlook in Europe to 2019 - Capacity and Capital Expenditure Forecasts with Details of All Operating and Planned Refineries" is a c …
  • イタリアの免疫診断市場2014
    This report provides an overview of the Italian immunodiagnostics market, including sales and market shares of leading reagent and instrument suppliers, as well as test volume and sales forecasts for chemistry, TDM, endocrine, cancer, immunoprotein and abused drug assays.[u]Table of Contents[/u]Busi …
  • Daicel Corporation (4202):企業の財務、戦略的SWOT分析
    Daicel Corporation (4202) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • フランスのハンドケア市場:市場規模、成長、予測
    SummaryHand cream is a rich moisturizer used to repair and prevent dry, cracked hands. Hand cream is technically different than hand lotion, though sometimes the terms are used interchangeably to refer to a moisturizer designed for the hands. Hand cream is, in general, thicker and richer with a more …
  • プルプル酸、アンモニウム塩の世界及び中国市場 2018年
    The 'Global and Chinese Purpuric Acid, Ammonium Salt Industry, 2013-2023 Market Research Report' is a professional and in-depth study on the current state of the global Purpuric Acid, Ammonium Salt industry with a focus on the Chinese market. The report provides key statistics on the market status o …
  • Lupin Limited (LUPIN):企業概要、財務及びSWOT分析
    Lupin Limited (LUPIN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • ペンテアの世界及び中国市場 2018年
    The 'Global and Chinese Pentair Ltd Industry, 2013-2023 Market Research Report' is a professional and in-depth study on the current state of the global Pentair Ltd industry with a focus on the Chinese market. The report provides key statistics on the market status of the Pentair Ltd manufacturers an …
  • 床置型高圧室の世界市場
    In this report, the global Floor-mounted Hyperbaric Chamber market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report split global into several key Regions, with sales (K Units), …
※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
※当市場調査資料(DIIR2014142 )"Pharyngitis:治療薬市場動向2014(市場規模、グローバルAPIメーカー、第Ⅲ相試験)" (英文: Pharyngitis- Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014)はDelveInsight社が調査・発行しており、H&Iグローバルリサーチが販売します。


◆H&Iグローバルリサーチのお客様(例)◆


※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
※H&Iグローバルリサーチ(登録第5864124号)及びH&I(登録第5783645号)はH&Iグローバルリサーチ株式会社の商標です。